Christopher Rowland

Washington, D.C.

Business reporter focused on the health-care economy's effects on patient health, costs and privacy

Education: University of Arizona, BS in Journalism

Chris Rowland reports on the business of health care for The Washington Post, which he joined in November 2018. He began his career at the Brattleboro Reformer, a small newspaper in southern Vermont, and remained focused on New England in subsequent posts at the Providence Journal and the Boston Globe. He developed expertise in government accountability coverage, the intersection of business and politics, and health care. Rowland became an editor in 2007 and oversaw the Globe's coverage of the Massachusetts State House and Boston City Hall. In 2009, he moved to Washington to lead the Globe
Latest from Christopher Rowland

Epilepsy drugs as ‘chemical restraint’ on rise in nursing homes

Nursing homes must keep patients and caregivers safe. But too often, experts say, patients with dementia are drugged as a matter of convenience, not for safety reasons.

November 17, 2022

Decades of neglect in nursing homes spur Biden plan for staff mandates

The industry opposes a federal minimum staff requirement, citing high costs and workforce shortages

November 15, 2022

Listen up: You can now buy hearing aids without a prescription

Starting Monday, buying a device to address mild or moderate hearing loss will be as easy as walking into a drug store. But it won't be cheap.

October 16, 2022

Seniors are stuck home alone as health aides flee for higher-paying jobs

As home-care aides become more scarce thanks to the pandemic and tight labor market, it is threatening the independence of a generation of older Americans who had planned to age in place.

September 25, 2022

Staffing during pandemic harmed nursing home residents, House panel says

The report increases pressure on nursing homes and the Biden administration to fix problems seen as contributing to the high rate of death of seniors from covid.

September 21, 2022

China competition spurs Biden push for domestic biotech subsidies

Biden’s executive order aims to boost biotech manufacturing and avoid losing dominance to China — as happened with the manufacturing of semiconductor chips.

September 12, 2022

Moderna sues Pfizer and BioNTech over coronavirus vaccine patent

The lawsuit, filed by Moderna, sets up a clash between rival vaccine makers who used novel mRNA technology to speed delivery of shots.

August 26, 2022

A challenge for antiabortion states: Doctors reluctant to work there

Recruiters say OB/GYNs are turning down offers, a warning for conservative-dominated states already experiencing shortages.

August 6, 2022

Groups that aid abortion patients pull back, fearing legal liability

Sources of assistance are drying up just as economically disadvantaged women and other pregnant people in states that have moved to ban abortion need money more than ever .

July 15, 2022